Vanda eyes first FDA-approved delayed sleep-wake disorder drug0ShareHealthVanda eyes first FDA-approved delayed sleep-wake disorder drug10 sources·Updated Oct 1, 2026·1 min read0Photo: Artem Podrez / Wikimedia Commons (Pexels)SponsoredSponsoredIn this story:🏷️VandaTagWhere do you stand?VandaSupportOpposeMore on this storyBack to NewsFinanceInflation, AI Fears Drive US Stock SelloffSeptember CPI rose 3.7% as core inflation beat forecasts; S&P 500 fell 1.1%, Nasdaq 1.9%, and CoreWeave bonds yielded above 15% distress levels.80 sourcesBusinessEncompass Boosts Two Innovator ETF Stakes by Over 675 PercentEncompass More Asset Management raised Growth Accelerated and U.S. Equity Accelerated ETF – Quarterly stakes by 675.8% and 676.3% in Q3, adding Power Buffer positions and cutting Ultra Buffer October.
